Search research articles
Contact Us
Filters
Showing results (1-10 of 476) with videos related to
Page
of 48
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
September 10, 2003
[Epidemiology of multiple sclerosis: environmental factors versus genetic factors]
Jun-ichi Kira
The Lancet. Neurology
|
July 10, 2003
Multiple sclerosis in the Japanese population
Jun-ichi Kira
Rinsho Shinkeigaku = Clinical Neurology
|
January 27, 2012
[Care network supporting patients with intractable diseases]
Jun-Ichi Kira
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
April 11, 2017
Unexpected exacerbations following initiation of disease-modifying drugs in neuromyelitis optica spectrum disorder: Which factor is responsible, anti-aquaporin 4 antibodies, B cells, Th1 cells, Th2 cells, Th17 cells, or others?
Jun-Ichi Kira
Journal of the Neurological Sciences
|
January 18, 2017
q-space Myelin Map imaging: A new imaging technique for treatment evaluation in multiple sclerosis
Jun-Ichi Kira
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
April 12, 2025
Treating Balo's concentric sclerosis in the monoclonal antibody era
Jun-Ichi Kira
The Lancet. Neurology
|
July 24, 2021
Redefining use of MRI for patients with multiple sclerosis
Jun-Ichi Kira
The Lancet. Neurology
|
December 21, 2007
MS: prevention of neural damage by early intervention
Jun-ichi Kira
Rinsho Shinkeigaku = Clinical Neurology
|
May 22, 2004
[Neural damage associated with allergic diseases: pathomechanism and therapy]
Jun-ichi Kira
Internal Medicine (Tokyo, Japan)
|
April 4, 2002
Atopy and neural damage
Jun-Ichi Kira
Page
of 48
Search research articles
Search
Showing results (1-10 of 476) with videos related to
Sort By:
Page
of 48
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
September 10, 2003
[Epidemiology of multiple sclerosis: environmental factors versus genetic factors]
Jun-ichi Kira
The Lancet. Neurology
|
July 10, 2003
Multiple sclerosis in the Japanese population
Jun-ichi Kira
Rinsho Shinkeigaku = Clinical Neurology
|
January 27, 2012
[Care network supporting patients with intractable diseases]
Jun-Ichi Kira
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
April 11, 2017
Unexpected exacerbations following initiation of disease-modifying drugs in neuromyelitis optica spectrum disorder: Which factor is responsible, anti-aquaporin 4 antibodies, B cells, Th1 cells, Th2 cells, Th17 cells, or others?
Jun-Ichi Kira
Journal of the Neurological Sciences
|
January 18, 2017
q-space Myelin Map imaging: A new imaging technique for treatment evaluation in multiple sclerosis
Jun-Ichi Kira
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
April 12, 2025
Treating Balo's concentric sclerosis in the monoclonal antibody era
Jun-Ichi Kira
The Lancet. Neurology
|
July 24, 2021
Redefining use of MRI for patients with multiple sclerosis
Jun-Ichi Kira
The Lancet. Neurology
|
December 21, 2007
MS: prevention of neural damage by early intervention
Jun-ichi Kira
Rinsho Shinkeigaku = Clinical Neurology
|
May 22, 2004
[Neural damage associated with allergic diseases: pathomechanism and therapy]
Jun-ichi Kira
Internal Medicine (Tokyo, Japan)
|
April 4, 2002
Atopy and neural damage
Jun-Ichi Kira
Page
of 48